Rashmi Kaul

Personal profile

Research Interests

Dr. Kaul's lab investigates how hormonal factors affect inflammation during Hepatitis C virus pathogenesis and liver cancer development. Her team also investigates the role of estrogen in regulation of inflammation during recurrent urinary tract infections by E. coli and also developing novel nanoparticle based therapy for killing intracellular bacteria or killing cancer cells.

Fingerprint Dive into the research topics where Rashmi Kaul is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

2 Similar Profiles

Autoimmune Experimental Myasthenia Gravis Medicine & Life Sciences

Cholinergic Receptors Medicine & Life Sciences

MHC Class I Genes Medicine & Life Sciences

Nanodiamonds Chemical Compounds

Animal Disease Models Medicine & Life Sciences

Hepatocellular Carcinoma Medicine & Life Sciences

MHC Class II Genes Medicine & Life Sciences

Estrogen Receptors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2017

1 Finished

Nanoparticles for Drug Delivery and Treatment of Urinary Tract Infections

Kaul, R.

Oklahoma Center for the Advancement of Science and Technology

1/09/16 → 31/08/17

Project: Research

Research Output 1983 2019

732 Citations
12 h-Index
23 Article
2 Review article
1 Letter

Characteristics of carcinoembryonic antigen-producing colorectal cancers: A population based study

Groover, S., Kaul, R., Johnston, S. E., Zhao, Y. D., Karippot, A. & Thirunavukarasu, P., 1 Jan 2019, In : Archive of Oncology. 25, 1, p. 1-8 8 p.

Research output: Contribution to journal › Article

Open Access

Carcinoembryonic Antigen

Colorectal Neoplasms

Odds Ratio

Population

Neoplasms

Estrogen receptor subtype agonist activation in human cutaneous squamous cell carcinoma cells modulates expression of CD55 and cyclin D1

Lan, J., Gao, X. H. & Kaul, R., 1 Jan 2019, In : EXCLI Journal. 18, p. 606-618 13 p.

Research output: Contribution to journal › Article

Cyclin D1

squamous cell carcinoma

cyclins

Estrogen Receptors

agonists

2 Citations (Scopus)

Nanodiamonds facilitate killing of intracellular uropathogenic e. Coli in an in vitro model of urinary tract infection pathogenesis

Iyer, J. K., Dickey, A., Rouhani, P., Kaul, A., Govindaraju, N., Singh, R. N. & Kaul, R., Jan 2018, In : PLoS ONE. 13, 1, e0191020.

Research output: Contribution to journal › Article

nanodiamonds

Nanodiamonds

urinary tract diseases

uropathogenic Escherichia coli

Uropathogenic Escherichia coli

11 Citations (Scopus)

Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis

Iyer, J. K., Kalra, M., Kaul, A., Payton, M. E. & Kaul, R., 7 Oct 2017, In : World Journal of Gastroenterology. 23, 37, p. 6802-6816 15 p.

Research output: Contribution to journal › Article

Chronic Hepatitis C

Estrogen Receptors

Hepacivirus

Hepatocellular Carcinoma

Liver

8 Citations (Scopus)

Purification and functionalization of nanodiamond to serve as a platform for amoxicillin delivery

Rouhani, P., Govindaraju, N., Iyer, J. K., Kaul, R., Kaul, A. & Singh, R. N., 1 Jun 2016, In : Materials Science and Engineering C. 63, p. 323-332 10 p.

Research output: Contribution to journal › Article

Nanodiamonds

Amoxicillin

purification

Purification

delivery